California hands down millions in fines to Anthem Blue Cross; “street medicine” aims to bring healthcare to the homeless in Atlanta; Johnson & Johnson claims its baby powder is safe.
Anthem Blue Cross in California was fined almost $9.6 million between January 2014 and November 2019 by the state’s Department of Managed Health Care (DMHC), according to California Healthline, for violations that included not covering out-of-network care that should have been covered and wrongly denying claims. That is close to 44% of all penalties for the period. In 2017 alone, Anthem was fined $5 million for letting customer issues drag on for too long, which was eventually negotiated down to $2.8 million and a promise to use $8.4 million for improvements. In total, DMHC has fined licensed health plans $73 million since 2000, its first year.
Mercy Care in Atlanta, Georgia, brings healthcare to the homeless on a daily basis, Kaiser Health News reports, spending close to $900,000 each year since 2013, when its street medicine program began. Outreach personnel include social workers, mental health specialists, and nursing students on 4-week rotations who strive to gain the trust of their often-stigmatized clientele before offering counseling, blood pressure measurements, and flu shots—among the many services they provide. In a non—Medicaid expansion state, Mercy Care hopes to prevent repeated visits to the emergency department, saving money in the process.
Following a voluntary October recall of 1 lot of its Baby Powder—33,000 bottles in the United States—Johnson & Johnson conducted 155 tests via 4 testing methods at 2 third-party labs, contesting claims by the FDA that the powder contains trace amounts of asbestos, according to Reuters. This follows testing also completed in October, with similar results. J&J states that the FDA’s results may be due to sample contamination or lab analyst error, possibly both. J&J has faced increasing scrutiny over the years from lawsuits over baby powder, opioids, and Risperdal, an antipsychotic, among others.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen